Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 25.56
(1.43%)
CNY 25.56
(1.43%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 188.49 Million CNY | 1.2% |
| 2022 | 189.96 Million CNY | -17.55% |
| 2021 | 226.09 Million CNY | -4.44% |
| 2020 | 238.85 Million CNY | -18.2% |
| 2019 | 240.23 Million CNY | -5.72% |
| 2018 | 334.78 Million CNY | 38.78% |
| 2017 | 246.01 Million CNY | 16.32% |
| 2016 | 217.12 Million CNY | 0.21% |
| 2015 | 189.62 Million CNY | -0.16% |
| 2014 | 186.29 Million CNY | 47.81% |
| 2013 | 139.34 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 47.61 Million CNY | 0.57% |
| 2024 Q1 | 50.45 Million CNY | 233.52% |
| 2024 Q3 | 44.33 Million CNY | -27.14% |
| 2023 FY | - CNY | 1.2% |
| 2023 Q3 | 72.86 Million CNY | -15.67% |
| 2023 Q2 | 86.4 Million CNY | 158.17% |
| 2023 Q1 | 33.46 Million CNY | 42.87% |
| 2023 Q4 | -47.17 Million CNY | -164.75% |
| 2022 Q2 | 44.87 Million CNY | -13.5% |
| 2022 Q1 | 51.88 Million CNY | 77.27% |
| 2022 FY | - CNY | -17.55% |
| 2022 Q4 | 23.42 Million CNY | -14.38% |
| 2022 Q3 | 27.35 Million CNY | -39.04% |
| 2021 Q2 | 43.79 Million CNY | -38.38% |
| 2021 Q1 | 71.06 Million CNY | -26.68% |
| 2021 Q3 | 45.62 Million CNY | 4.19% |
| 2021 Q4 | 29.26 Million CNY | -35.85% |
| 2021 FY | - CNY | -4.44% |
| 2020 FY | - CNY | -18.2% |
| 2020 Q4 | 96.93 Million CNY | 207.43% |
| 2020 Q2 | 60.57 Million CNY | 249.74% |
| 2020 Q1 | 17.32 Million CNY | -79.36% |
| 2020 Q3 | 31.53 Million CNY | -47.95% |
| 2019 Q3 | 36.31 Million CNY | -63.24% |
| 2019 Q1 | 35.32 Million CNY | -65.75% |
| 2019 FY | - CNY | -5.72% |
| 2019 Q4 | 83.9 Million CNY | 131.07% |
| 2019 Q2 | 98.77 Million CNY | 179.61% |
| 2018 Q2 | 75.96 Million CNY | 63.74% |
| 2018 FY | - CNY | 38.78% |
| 2018 Q4 | 103.14 Million CNY | 122.51% |
| 2018 Q3 | 46.35 Million CNY | -38.98% |
| 2018 Q1 | 46.39 Million CNY | -4.86% |
| 2017 FY | - CNY | 16.32% |
| 2017 Q3 | 38.02 Million CNY | 0.0% |
| 2017 Q4 | 48.76 Million CNY | 28.23% |
| 2016 FY | - CNY | 0.21% |
| 2015 FY | - CNY | -0.16% |
| 2014 FY | - CNY | 47.81% |
| 2013 FY | - CNY | 0.0% |